July 29 (Reuters) - bioAffinity Technologies Inc BIAF.O:
CASE STUDY: CYPATH® LUNG DETECTS STAGE 1A LUNG CANCER IN HIGH-RISK PATIENT WITH INCONCLUSIVE IMAGING AND LOW-RISK SERUM TEST RESULTS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.